| NDC Code | 60219-2092-3 |
|---|
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (60219-2092-3) |
|---|
| Product NDC | 60219-2092 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Emtricitabine And Tenofovir Disoproxil Fumarate |
|---|
| Non-Proprietary Name | Emtricitabine And Tenofovir Disoproxil Fumarate |
|---|
| Dosage Form | TABLET, FILM COATED |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20180826 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA209721 |
|---|
| Manufacturer | Amneal Pharmaceuticals NY LLC |
|---|
| Substance Name | EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE |
|---|
| Strength | 100; 150 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
|---|